Showing results (11-20 of 457) with videos related to

Sort By:
Pageof 46
Seminars in Cutaneous Medicine and Surgery|October 6, 2005
An analysis of recent antitrust issues affecting specialty practice: is dermatology immune?Allan Gibofsky
Rheumatology and Therapy|August 9, 2024
Summary of Research: Effects of Adalimumab-adbm Versus Adalimumab Reference Product on Patient-Reported Outcomes in Rheumatoid Arthritis: Results from VOLTAIRE-RAVibeke Strand
Autoimmunity Reviews|February 24, 2007
Lessons learned from clinical trials in SLEVibeke Strand
Journal of Cardiovascular Pharmacology|June 21, 2006
Expectations from patients with rheumatoid arthritis regarding COX-2s: cutting to the heart of the matterVibeke Strand
Lancet (London, England)|December 25, 2007
Are COX-2 inhibitors preferable to non-selective non-steroidal anti-inflammatory drugs in patients with risk of cardiovascular events taking low-dose aspirin?Vibeke Strand
Expert Review of Clinical Immunology|March 3, 2022
Patient-reported outcomes and realistic clinical endpoints for JAK inhibitors in rheumatoid arthritisVibeke Strand
Rheumatology and Therapy|June 11, 2025
Summary of Research: Immunogenicity of Adalimumab Reference Product and Adalimumab-adbm in Patients with Rheumatoid Arthritis, Crohn's Disease, and Chronic Plaque Psoriasis: A Pooled Analysis of the VOLTAIRE trialsVibeke Strand
Clinical Therapeutics|September 4, 2012
Need to develop new nonsteroidal anti-inflammatory drug formulationsBill McCarberg, Allan Gibofsky
Current Opinion in Rheumatology|March 8, 2011
Methotrexate versus leflunomide in rheumatoid arthritis: what is new in 2011?Ora Singer, Allan Gibofsky
Expert Opinion on Pharmacotherapy|April 19, 2013
Delayed-release prednisone - a new approach to an old therapyFrank Buttgereit, Allan Gibofsky
Pageof 46